Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 244.00
Bid: 243.50
Ask: 244.50
Change: 1.00 (0.41%)
Spread: 1.00 (0.411%)
Open: 243.50
High: 245.00
Low: 243.50
Prev. Close: 243.00
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update

11 Nov 2022 15:53

RNS Number : 2010G
AVI Global Trust PLC
11 November 2022
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 October 2022.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/agt/content/uploads/2022/11/AGT-October-2022-1.pdf

 

Performance Total Return

 

This investment management report relates to performance figures to 31 October 2022.

 

Month

Fiscal Yr*

to date

Calendar Yr

to date

AGT NAV1

2.4%

2.4%

-10.9%

MSCI ACWI Ex US2

-0.1%

-0.1%

-11.0%

MSCI ACWI1

2.8%

2.8%

-7.2%

 

1

Source: Morningstar. All NAV figures are cum-fair values.

2

From 1st October 2013 the lead benchmark was changed to the MSCI ACWI ex US (£) Index. The investment management fee was changed to 0.7% of net assets and the performance related fee eliminated.

 

* All return figures in GBP. AVI Global Trust financial year commences on the 1st October. All figures published before the fiscal results announcement are AVI estimates and subject to change.

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +2.4% in October.

There were a number of strong performers over the month, with KKR, Apollo, Pershing Square Holdings, Schibsted and FEMSA all contributing >45bps. Wacom and IAC were notable detractors, reducing returns by -41bps and -46bps, respectively.

 

Citywire Investment Trust awards

 

In early November AVI Global Trust won the award of the Best Global Equities Trust at the Citywire Investment Trust awards 2022. The award is based on the best risk-adjusted growth in NAV over a three-year period to August 2022. Our focus has been on buying good quality businesses trading at attractive valuations, and combining this with active engagement to unlock value at our portfolio companies; enabling them to thrive. The Trust's performance over the past three years has been testament to the enduring strengths of the unique and differentiated strategy we have employed since 1985. This strategy continues to deliver consistent returns and we remain confident in our portfolio's long-term prospects.

 

 

Listed PE/VC:

Over the last few months, we have established small positions across several (mainly London-listed) closed-end funds offering exposure to private equity and venture capital investments.

These collectively now represent almost 8% of AGT's NAV, and trade at abnormally wide discounts to NAV. The market is clearly sceptical that NAVs have been marked down sufficiently but - while perhaps unsatisfying from a purist's standpoint - the reality has always been that private equity NAVs tend to lag public markets in both directions: on the way up and, in the current market conditions, on the way down.

The discounts on our basket of holdings still stand at dislocated levels even after applying what we believe to be conservative haircuts to valuations, while activity in the secondary market for LP stakes suggests the gap between private secondary discounts and those in the listed market has widened materially. Indeed, we recently saw one of our investee companies use the proceeds from a secondary sale of some of its underlying interests in private equity funds to fund a buyback of its own shares. We understand the discount on the private secondary sale was significantly narrower than the level at which the share repurchases were made.

On this point, we have been pleased to see several listed private equity funds announce share buyback programmes. This stands in contrast to the situation faced by most funds in the wake of the Global Financial Crisis when many were forced sellers (either of assets in the secondary market or of their own shares via rescue rights issues) due to overly extended balance sheets. This time is different in that respect, with commitments and gearing levels at relatively modest levels, allowing funds to take advantage of the wide discounts at which their shares are trading. There is usually a decline in investment activity in times such as these, as buyers and sellers adjust expectations and take a while to come together at a clearing price. However, if funds can demonstrate a continued pattern of realisations at premia to carrying values, we would expect that to act as a catalyst in driving a re-rating.

 

Wacom:

Over the last year and half AGT has built a position in Wacom, the world's leading digital writing tablet manufacturer, with an estimated 60% market share. We wrote about the company in the interim report, when strong share price performance made the company one of the largest contributors. However subsequent returns have been weaker, with the shares declining -9% in October and now -28% calendar year to date. The depreciation of the Yen has further impaired returns.

While Wacom's B2B business - which boasts Disney and Samsung as customers - has been resilient with a growing customer base and high adoption of digital pens, the consumer business has suffered from a demand-led slowdown. Combined with higher component costs the consumer business is forecast to see full-year profits decline -92% YoY resulting in total profits forecasted to fall -54%. This has been a painful adjustment for the market.

However, our belief in Wacom's technology and long-term growth potential is unchanged, and the market's myopic focus presents an opportunity to take advantage of the price dislocation. Using normalised earnings, Wacom trades on only 6x EV/EBIT, a remarkably low valuation considering Wacom's technology and structural growth tailwinds from the increased adoption of digital writing solutions. As a top three shareholder across AVI funds, we are working closely with management to address the recent underperformance and ensure efforts are being made to maximise shareholder value. Our estimated potential upside to the current share price is in the order of +100%.

 

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% of NAV

KKR

53

5.9

Apollo Global Mgmt.

52

3.8

Pershing Square Holdings

50

9.3

Schibsted ASA

48

3.7

FEMSA

45

4.5

 

Largest Detractors

1- month contribution

bps

% of NAV

Wacom

-46

2.8

IAC

-41

2.3

Symphony International Holdings

-27

3.0

Godrej Industries

-24

3.2

Jardine Matheson

-13

1.0

 

 

Link Company Matters Limited

Corporate Secretary

 

11 November 2022

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCFLFSELALLLIF
Date   Source Headline
3rd Jun 20243:59 pmRNSNet Asset Value(s)
3rd Jun 202410:12 amRNSTotal Voting Rights
31st May 20243:47 pmRNSNet Asset Value(s)
30th May 20243:06 pmRNSNet Asset Value(s)
29th May 20245:31 pmRNSTransaction in Own Shares
29th May 20241:15 pmRNSNet Asset Value(s)
28th May 20243:48 pmRNSNet Asset Value(s)
24th May 20243:08 pmRNSNet Asset Value(s)
23rd May 20245:14 pmRNSTransaction in Own Shares
23rd May 20242:32 pmRNSNet Asset Value(s)
22nd May 202412:36 pmRNSNet Asset Value(s)
21st May 20245:45 pmRNSTransaction in Own Shares
21st May 20244:48 pmRNSHolding(s) in Company
21st May 20241:11 pmRNSNet Asset Value(s)
20th May 20241:08 pmRNSNet Asset Value(s)
17th May 202412:50 pmRNSNet Asset Value(s)
16th May 20245:55 pmRNSTransaction in Own Shares
16th May 20242:44 pmRNSHolding(s) in Company
16th May 20241:34 pmRNSNet Asset Value(s)
15th May 20245:43 pmRNSTransaction in Own Shares
15th May 20245:19 pmRNSMonthly Factsheet
15th May 20241:20 pmRNSNet Asset Value(s)
14th May 20241:05 pmRNSNet Asset Value(s)
13th May 20241:00 pmRNSNet Asset Value(s)
10th May 20244:43 pmRNSHolding(s) in Company
10th May 20241:35 pmRNSNet Asset Value(s)
9th May 20245:55 pmRNSTransaction in Own Shares
9th May 202412:46 pmRNSNet Asset Value(s)
8th May 20241:27 pmRNSNet Asset Value(s)
7th May 20241:18 pmRNSNet Asset Value(s)
3rd May 20242:08 pmRNSNet Asset Value(s)
2nd May 20245:43 pmRNSTransaction in Own Shares
2nd May 20241:55 pmRNSNet Asset Value(s)
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.